Stock Scorecard
Stock Summary for Fulgent Genetics Inc (FLGT) - $21.70 as of 3/28/2024 9:32:02 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for FLGT
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for FLGT
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for FLGT
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for FLGT
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for FLGT
Financial Details for FLGT
Company Overview |
|
---|---|
Ticker | FLGT |
Company Name | Fulgent Genetics Inc |
Country | USA |
Description | Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SERVICES-MEDICAL LABORATORIES |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/3/2024 |
Stock Price History |
|
Last Day Price | 21.70 |
Last Day Price Updated | 3/28/2024 9:32:02 PM EST |
Last Day Volume | 154,075 |
Average Daily Volume | 269,071 |
52-Week High | 44.09 |
52-Week Low | 21.23 |
Last Price to 52 Week Low | 2.21% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 261.00 |
Sector PE | 60.76 |
5-Year Average PE | 3.74 |
Free Cash Flow Ratio | 6.64 |
Industry Free Cash Flow Ratio | 16.58 |
Sector Free Cash Flow Ratio | 31.04 |
Current Ratio Most Recent Quarter | 6.96 |
Total Cash Per Share | 3.27 |
Book Value Per Share Most Recent Quarter | 38.31 |
Price to Book Ratio | 0.57 |
Industry Price to Book Ratio | 2.70 |
Sector Price to Book Ratio | 21.66 |
Price to Sales Ratio Twelve Trailing Months | 2.23 |
Industry Price to Sales Ratio Twelve Trailing Months | 1.49 |
Sector Price to Sales Ratio Twelve Trailing Months | 8.77 |
Share Statistics |
|
Total Shares Outstanding | 29,784,800 |
Market Capitalization | 646,330,160 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -98.60% |
Annual Earnings Growth | -217.03% |
Reported EPS 12 Trailing Months | -5.63 |
Reported EPS Past Year | -0.41 |
Reported EPS Prior Year | 5.70 |
Net Income Twelve Trailing Months | -167,825,000 |
Net Income Past Year | -167,825,000 |
Net Income Prior Year | 143,403,000 |
Quarterly Revenue Growth YOY | 4.10% |
5-Year Revenue Growth | 68.41% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 97,473,000 |
Total Cash Past Year | 97,473,000 |
Total Cash Prior Year | 79,506,000 |
Net Cash Position Most Recent Quarter | 93,326,000 |
Net Cash Position Past Year | 93,326,000 |
Long Term Debt Past Year | 4,147,000 |
Long Term Debt Prior Year | 5,639,000 |
Total Debt Most Recent Quarter | 4,147,000 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 1,136,101,000 |
Total Stockholder Equity Prior Year | 1,266,685,000 |
Total Stockholder Equity Most Recent Quarter | 1,136,101,000 |
Options |
|
Put/Call Ratio | 0.08 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.80 |
MACD Signal | -0.82 |
20-Day Bollinger Lower Band | 20.84 |
20-Day Bollinger Middle Band | 25.80 |
20-Day Bollinger Upper Band | 30.75 |
Beta | 1.45 |
RSI | 42.30 |
50-Day SMA | 30.25 |
200-Day SMA | 51.94 |
System |
|
Modified | 3/28/2024 12:46:08 AM EST |